MyFinsight
Home
Blog
About
Contact
Download
Download image
Revenues
$237,258K
Interest income
$1,596K
Proceeds from maturities
of investments
$40,000K
Prepaid clinical
services, long-term
-$34,898K
Net proceeds from
issuance of common...
$4,201K
Proceeds from issuance of
treasury stock under the...
$181K
Proceeds from sale of
property and equipment
$5K
Accrued and other
liabilities
$33,735K
Net income (loss)
$16,327K
Deferred
revenue-Collaboration Revenue
$14,976K
Accounts payable
$14,639K
Depreciation and
amortization
$8,579K
Stock-based compensation
$8,314K
Non-cash interest
expense related to sale...
$2,823K
Loss on disposal of
property and equipment
-$38K
Net proceeds from
issuance of common...
$53K
Proceeds from issuance of
common stock upon...
$3K
Canceled cashflow
$222,527K
Net cash provided by
(used in) investing...
$16,632K
Net cash provided by
(used in) operating...
$7,714K
Net cash provided by
financing activities
$4,239K
Canceled cashflow
$23,373K
Canceled cashflow
$126,615K
Canceled cashflow
$199K
Research and development
expense-Covid19Program
$155,049K
Research and development
expense-Internal Research And...
$41,731K
General and
administrative
$17,608K
Research and development
expense-Norovirus Program
$3,638K
Non-cash interest
expense related to sale...
$2,823K
Research and development
expense-Preclinical Research
$767K
Income tax expense
(benefit)
$476K
Research and development
expense-Other Programs
$345K
Research and development
expense-Process Development...
$46K
Other segment items
$44K
Net increase
(decrease) in cash and cash...
$28,585K
Purchases of investments
$23,228K
Purchases of property and
equipment
$145K
Deferred
revenue-Government Contract
-$65,332K
Unbilled receivable from
government contracts
$30,573K
Prepaid expenses and
other assets
$16,103K
Accounts receivable
$8,803K
Non-cash revenue related
to sale of future...
$4,521K
Gain on modification
of lease liability
$1,005K
Amortization of discount on
short-term investments,...
$278K
Shares acquired to
settle employee tax...
$199K
Back
Back
Cash Flow
source: myfinsight.com
Vaxart, Inc. (VXRT)
Vaxart, Inc. (VXRT)